CAMBRIDGE, Mass.--(BUSINESS WIRE)--Good Start Genetics, Inc., an innovative molecular diagnostics company developing the new gold standard in carrier screening, announced today that it will participate in the 2013 Biotech Showcase in San Francisco, CA. Don Hardison, president and CEO of Good Start Genetics, is scheduled to present Monday, Jan. 7, at 9:45 a.m. (PST).
Don Hardison will be available for one-on-one meetings with investors and media attending the conference.
|
Event |
Biotech Showcase 2013 | ||
|
Date |
Monday, Jan. 7 | ||
|
Time |
9:45 a.m. PST | ||
|
Place |
Mission I (Track B) | ||
| Parc 55 Wyndham-Union Square | |||
| San Francisco, CA |
About Good Start Genetics, Inc.
Good Start Genetics is setting the new gold standard in carrier screening by making testing for the most comprehensive set of known and novel disease-causing mutations accessible for routine clinical practice. After years of development and rigorous validation, Good Start Genetics has harnessed the power of next-generation sequencing and other best-in-class technologies to provide highly accurate, actionable, and affordable tests for all ACOG and ACMG recommended disorders. For these reasons, fertility specialists and their patients can have a high degree of confidence in their carrier screening results, and no longer have to compromise accuracy for price. For more information, please visit www.goodstartgenetics.com.